Literature DB >> 3748452

Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity.

P J Elliott, C B Nemeroff.   

Abstract

Microinjections of neurotensin (NT) into the ventral tegmental area (VTA) of the rat increases locomotor activity. This effect on locomotion is potentiated by daily infusions of NT; in contrast a different injection schedule, i.e. every 48 h, had no such effect. In addition, daily NT injections in the VTA do not alter the locomotor response to a relatively low dose (0.5 mg/kg) of D-amphetamine. These results provide further evidence that NT can modulate the mesolimbic dopamine pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3748452     DOI: 10.1016/0304-3940(86)90149-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.

Authors:  Elizabeth N Holly; Bree Ebrecht; Adam J Prus
Journal:  Eur Neuropsychopharmacol       Date:  2011-01-28       Impact factor: 4.600

Review 2.  Lateral hypothalamic area neuropeptides modulate ventral tegmental area dopamine neurons and feeding.

Authors:  Patricia Perez-Bonilla; Krystal Santiago-Colon; Gina M Leinninger
Journal:  Physiol Behav       Date:  2020-05-31

3.  Neurotensin Receptor-1 Identifies a Subset of Ventral Tegmental Dopamine Neurons that Coordinates Energy Balance.

Authors:  Hillary L Woodworth; Hannah M Batchelor; Bethany G Beekly; Raluca Bugescu; Juliette A Brown; Gizem Kurt; Patrick M Fuller; Gina M Leinninger
Journal:  Cell Rep       Date:  2017-08-22       Impact factor: 9.423

4. 

Authors:  Laura E Schroeder; Ryan Furdock; Cristina Rivera Quiles; Gizem Kurt; Patricia Perez-Bonilla; Angela Garcia; Crystal Colon-Ortiz; Juliette Brown; Raluca Bugescu; Gina M Leinninger
Journal:  Neuropeptides       Date:  2019-05-06       Impact factor: 3.286

5.  Lateral Hypothalamic Mc3R-Expressing Neurons Modulate Locomotor Activity, Energy Expenditure, and Adiposity in Male Mice.

Authors:  Hongjuan Pei; Christa M Patterson; Amy K Sutton; Korri H Burnett; Martin G Myers; David P Olson
Journal:  Endocrinology       Date:  2019-02-01       Impact factor: 4.736

6.  Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference.

Authors:  Klara Felszeghy; José Manuel Espinosa; Hélène Scarna; Anne Bérod; William Rostène; Didier Pélaprat
Journal:  Neuropsychopharmacology       Date:  2007-03-14       Impact factor: 7.853

7.  Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity.

Authors:  Darren Opland; Amy Sutton; Hillary Woodworth; Juliette Brown; Raluca Bugescu; Adriana Garcia; Lyndsay Christensen; Christopher Rhodes; Martin Myers; Gina Leinninger
Journal:  Mol Metab       Date:  2013-08-07       Impact factor: 7.422

8.  Comparison of the locomotor-activating effects of bicuculline infusions into the preoptic area and ventral pallidum.

Authors:  Daniel S Zahm; Zachary M Schwartz; Heather N Lavezzi; Leora Yetnikoff; Kenneth P Parsley
Journal:  Brain Struct Funct       Date:  2013-02-20       Impact factor: 3.270

9.  Repeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: A role for NMDA receptors.

Authors:  David Voyer; Daniel Lévesque; Pierre-Paul Rompré
Journal:  Neuropharmacology       Date:  2016-06-05       Impact factor: 5.250

10.  Blockade of neurotensin-induced motor activity by inhibition of protein kinase.

Authors:  P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.